Literature DB >> 33236718

Risk assessments and structured care interventions for prevention of foot ulceration in diabetes: development and validation of a prognostic model.

Fay Crawford1,2, Francesca M Chappell3, James Lewsey3, Richard Riley4, Neil Hawkins5, Donald Nicolson1, Robert Heggie5, Marie Smith6, Margaret Horne7, Aparna Amanna1, Angela Martin8, Saket Gupta8, Karen Gray1, David Weller7, Julie Brittenden9, Graham Leese10.   

Abstract

BACKGROUND: Diabetes-related foot ulcers give rise to considerable morbidity, generate a high monetary cost for health and social care services and precede the majority of diabetes-related lower extremity amputations. There are many clinical prediction rules in existence to assess risk of foot ulceration but few have been subject to validation.
OBJECTIVES: Our objectives were to produce an evidence-based clinical pathway for risk assessment and management of the foot in people with diabetes mellitus to estimate cost-effective monitoring intervals and to perform cost-effectiveness analyses and a value-of-information analysis.
DESIGN: We developed and validated a prognostic model using predictive modelling, calibration and discrimination techniques. An overview of systematic reviews already completed was followed by a review of randomised controlled trials of interventions to prevent foot ulceration in diabetes mellitus. A review of the health economic literature was followed by the construction of an economic model, an analysis of the transitional probability of moving from one foot risk state to another, an assessment of cost-effectiveness and a value-of-information analysis.
INTERVENTIONS: The effects of simple and complex interventions and different monitoring intervals for the clinical prediction rules were evaluated. MAIN OUTCOME MEASURE: The main outcome was the incidence of foot ulceration. We compared the new clinical prediction rules in conjunction with the most effective preventative interventions at different monitoring intervals with a 'treat-all' strategy. DATA SOURCES: Data from an electronic health record for 26,154 people with diabetes mellitus in one Scottish health board were used to estimate the monitoring interval. The Prediction Of Diabetic foot UlcerationS (PODUS) data set was used to develop and validate the clinical prediction rule. REVIEW
METHODS: We searched for eligible randomised controlled trials of interventions using search strategies created for Ovid® (Wolters Kluwer, Alphen aan den Rijn, the Netherlands), MEDLINE, EMBASE and the Cochrane Central Register of Controlled Trials. Randomised controlled trials in progress were identified via the International Standard Randomised Controlled Trial Number Registry and systematic reviews were identified via PROSPERO. Databases were searched from inception to February 2019.
RESULTS: The clinical prediction rule was found to accurately assess the risk of foot ulceration. Digital infrared thermometry, complex interventions and therapeutic footwear with offloading devices were found to be effective in preventing foot ulcers. The risk of developing a foot ulcer did not change over time for most people. We found that interventions to prevent foot ulceration may be cost-effective but there is uncertainty about this. Digital infrared thermometry and therapeutic footwear with offloading devices may be cost-effective when used to treat all people with diabetes mellitus regardless of their ulcer risk. LIMITATIONS: The threats to the validity of the results in some randomised controlled trials in the review and the large number of missing data in the electronic health record mean that there is uncertainty in our estimates.
CONCLUSIONS: There is evidence that interventions to prevent foot ulceration are effective but it is not clear who would benefit most from receiving the interventions. The ulceration risk does not change over an 8-year period for most people with diabetes mellitus. A change in the monitoring interval from annually to every 2 years for those at low risk would be acceptable. FUTURE WORK RECOMMENDATIONS: Improving the completeness of electronic health records and sharing data would help improve our knowledge about the most clinically effective and cost-effective approaches to prevent foot ulceration in diabetes mellitus. STUDY REGISTRATION: This study is registered as PROSPERO CRD42016052324. FUNDING: This project was funded by the National Institute for Health Research (NIHR) Health Technology Assessment programme and will be published in full in Health Technology Assessment; Vol. 24, No. 62. See the NIHR Journals Library website for further project information.

Entities:  

Keywords:  CLINICAL PATHWAY; CLINICAL PREDICTION RULE; COST-EFFECTIVENESS; COST–BENEFIT ANALYSIS; DIABETES, FOOT ULCERS; ECONOMIC MODELS; RISK ASSESSMENTS

Year:  2020        PMID: 33236718      PMCID: PMC7768791          DOI: 10.3310/hta24620

Source DB:  PubMed          Journal:  Health Technol Assess        ISSN: 1366-5278            Impact factor:   4.014


  143 in total

1.  Screening techniques to identify people at high risk for diabetic foot ulceration: a prospective multicenter trial.

Authors:  H Pham; D G Armstrong; C Harvey; L B Harkless; J M Giurini; A Veves
Journal:  Diabetes Care       Date:  2000-05       Impact factor: 19.112

2.  Cost-effectiveness of treating deep diabetic foot ulcers with Promogran in four European countries.

Authors:  O Ghatnekar; M Willis; U Persson
Journal:  J Wound Care       Date:  2002-02       Impact factor: 2.072

3.  External validation and optimisation of a model for predicting foot ulcers in patients with diabetes.

Authors:  M Monteiro-Soares; M Dinis-Ribeiro
Journal:  Diabetologia       Date:  2010-04-06       Impact factor: 10.122

4.  Stratification of foot ulcer risk in patients with diabetes: a population-based study.

Authors:  G P Leese; F Reid; V Green; R McAlpine; S Cunningham; A M Emslie-Smith; A D Morris; B McMurray; A C Connacher
Journal:  Int J Clin Pract       Date:  2006-05       Impact factor: 2.503

5.  The North-West Diabetes Foot Care Study: incidence of, and risk factors for, new diabetic foot ulceration in a community-based patient cohort.

Authors:  C A Abbott; A L Carrington; H Ashe; S Bath; L C Every; J Griffiths; A W Hann; A Hussein; N Jackson; K E Johnson; C H Ryder; R Torkington; E R E Van Ross; A M Whalley; P Widdows; S Williamson; A J M Boulton
Journal:  Diabet Med       Date:  2002-05       Impact factor: 4.359

Review 6.  A systematic review and individual patient data meta-analysis of prognostic factors for foot ulceration in people with diabetes: the international research collaboration for the prediction of diabetic foot ulcerations (PODUS).

Authors:  Fay Crawford; Genevieve Cezard; Francesca M Chappell; Gordon D Murray; Jacqueline F Price; Aziz Sheikh; Colin R Simpson; Gerard P Stansby; Matthew J Young
Journal:  Health Technol Assess       Date:  2015-07       Impact factor: 4.014

7.  Foot infections in diabetic patients. Decision and cost-effectiveness analyses.

Authors:  M H Eckman; S Greenfield; W C Mackey; J B Wong; S Kaplan; L Sullivan; K Dukes; S G Pauker
Journal:  JAMA       Date:  1995-03-01       Impact factor: 56.272

Review 8.  Prevention of foot ulcers in the at-risk patient with diabetes: a systematic review.

Authors:  J J van Netten; P E Price; L A Lavery; M Monteiro-Soares; A Rasmussen; Y Jubiz; S A Bus
Journal:  Diabetes Metab Res Rev       Date:  2016-01       Impact factor: 4.876

9.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.

Authors:  David Moher; Alessandro Liberati; Jennifer Tetzlaff; Douglas G Altman
Journal:  PLoS Med       Date:  2009-07-21       Impact factor: 11.069

10.  A systematic review and meta-analysis of patient education in preventing and reducing the incidence or recurrence of adult diabetes foot ulcers (DFU).

Authors:  P Adiewere; R B Gillis; S Imran Jiwani; A Meal; I Shaw; G G Adams
Journal:  Heliyon       Date:  2018-05-02
View more
  2 in total

1.  Reliability of the evidence to guide decision-making in foot ulcer prevention in diabetes: an overview of systematic reviews.

Authors:  Fay Crawford; Donald J Nicolson; Aparna E Amanna; Marie Smith
Journal:  BMC Med Res Methodol       Date:  2022-10-20       Impact factor: 4.612

2.  Australian guideline on wound classification of diabetes-related foot ulcers: part of the 2021 Australian evidence-based guidelines for diabetes-related foot disease.

Authors:  Emma J Hamilton; Joanna Scheepers; Hayley Ryan; Byron M Perrin; James Charles; Jane Cheney; Stephen M Twigg
Journal:  J Foot Ankle Res       Date:  2021-12-03       Impact factor: 2.303

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.